Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 247 Neoplasms 174 Prostatic Neoplasms 151 Colorectal Neoplasms 114 Lung Neoplasms 102 Leukemia, Myeloid, Acute 82 Pancreatic Neoplasms 77 Carcinoma, Non-Small-Cell Lung 77 Multiple Myeloma 66 Brain Neoplasms 59 Glioblastoma 58 Precursor Cell Lymphoblastic Leukemia-Lymphoma 57 Melanoma 53 Carcinoma, Hepatocellular 50 Ovarian Neoplasms 47 Head and Neck Neoplasms 46 Uterine Cervical Neoplasms 45 Neoplasm Metastasis 43 Sarcoma 41 Glioma 41 Stomach Neoplasms 40 Squamous Cell Carcinoma of Head and Neck 37 Recurrence 37 Hematologic Neoplasms 37 Carcinoma, Renal Cell 37 Lymphoma, Non-Hodgkin 35 Esophageal Neoplasms 35 Rectal Neoplasms 34 Myelodysplastic Syndromes 34 Lymphoma 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Localized Prostate Cancer × 30 days × Clear all

NCT06825091 2026-06-02

ASPIRE

University Health Network, Toronto

Phase 3 Recruiting

Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡